| Chronic kidney disease AC Webster, EV Nagler, RL Morton, P Masson The lancet 389 (10075), 1238-1252, 2017 | 4456 | 2017 |
| Cancer incidence before and after kidney transplantation CM Vajdic, SP McDonald, MRE McCredie, MT Van Leeuwen, JH Stewart, ... Jama 296 (23), 2823-2831, 2006 | 1323 | 2006 |
| Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data AC Webster, RC Woodroffe, RS Taylor, JR Chapman, JC Craig Bmj 331 (7520), 810, 2005 | 822 | 2005 |
| The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies RL Morton, A Tong, K Howard, P Snelling, AC Webster BmJ 340, 2010 | 658 | 2010 |
| A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments M Wyld, RL Morton, A Hayen, K Howard, AC Webster Public Library of Science 9 (9), e1001307, 2012 | 613 | 2012 |
| Sirolimus is associated with new-onset diabetes in kidney transplant recipients O Johnston, CL Rose, AC Webster, JS Gill Journal of the American Society of Nephrology 19 (7), 1411-1418, 2008 | 513 | 2008 |
| Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials EM Hodson, CA Jones, AC Webster, GFM Strippoli, PG Barclay, K Kable, ... The Lancet 365 (9477), 2105-2115, 2005 | 486 | 2005 |
| Interventions for smoking cessation and reduction in individuals with schizophrenia DT Tsoi, M Porwal, AC Webster Cochrane Database of Systematic Reviews, 2013 | 446 | 2013 |
| Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients EM Hodson, M Ladhani, AC Webster, GFM Strippoli, JC Craig Cochrane database of systematic reviews, 2013 | 438 | 2013 |
| Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials AC Webster, VWS Lee, JR Chapman, JC Craig Transplantation 81 (9), 1234-1248, 2006 | 434 | 2006 |
| Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients AC Webster, RRS Taylor, JR Chapman, JC Craig Cochrane Database of Systematic Reviews, 2005 | 421* | 2005 |
| Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15 183 recipients AC Webster, JC Craig, JM Simpson, MP Jones, JR Chapman American Journal of Transplantation 7 (9), 2140-2151, 2007 | 368 | 2007 |
| Cancer in the transplant recipient JR Chapman, AC Webster, G Wong Cold Spring Harbor perspectives in medicine 3 (7), a015677, 2013 | 355 | 2013 |
| Interleukin 2 receptor antagonists for kidney transplant recipients AC Webster, LP Ruster, RG McGee, SL Matheson, GY Higgins, NS Willis, ... Cochrane Database of Systematic Reviews, 2010 | 354 | 2010 |
| Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis P Masson, AC Webster, M Hong, R Turner, RI Lindley, JC Craig Nephrology Dialysis Transplantation 30 (7), 1162-1169, 2015 | 342 | 2015 |
| Association of CKD and cancer risk in older people G Wong, A Hayen, JR Chapman, AC Webster, JJ Wang, P Mitchell, ... Journal of the American Society of Nephrology 20 (6), 1341-1350, 2009 | 338 | 2009 |
| Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis E O’Lone, M Connors, P Masson, S Wu, PJ Kelly, D Gillespie, D Parker, ... American Journal of Kidney Diseases 67 (6), 925-935, 2016 | 283 | 2016 |
| Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials1 AC Webster, EG Playford, G Higgins, JR Chapman, JC Craig Transplantation 77 (2), 166-176, 2004 | 282 | 2004 |
| Iodine supplementation for women during the preconception, pregnancy and postpartum period KB Harding, JP Peña‐Rosas, AC Webster, CMY Yap, BA Payne, E Ota, ... Cochrane Database of Systematic Reviews, 2017 | 263 | 2017 |
| Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis SC Palmer, L Di Micco, M Razavian, JC Craig, V Perkovic, F Pellegrini, ... Annals of internal medicine 156 (6), 445-459, 2012 | 261 | 2012 |
Jonathan C Craig, Jonathan CraigCollege of Medicine and Public Health, Flinders Universityflinders.edu.au의 이메일 확인됨